2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신진호 | - |
dc.contributor.author | 박정배 | - |
dc.contributor.author | 김광일 | - |
dc.contributor.author | 김주한 | - |
dc.contributor.author | 양동현 | - |
dc.contributor.author | 변욱범 | - |
dc.contributor.author | 김영권 | - |
dc.contributor.author | 김근호 | - |
dc.contributor.author | 채성철 | - |
dc.contributor.author | 대한고혈압학회 | - |
dc.date.accessioned | 2022-07-15T23:45:55Z | - |
dc.date.available | 2022-07-15T23:45:55Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2015-04 | - |
dc.identifier.issn | 2635-6325 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/157626 | - |
dc.description.abstract | Treatment strategies are provided in accordance with the level of global cardiovascular risk,from lifestyle modification in the lower risk group to more comprehensive treatment in the higher risk group. Considering the common trend of combination drug regimen, the choice of the first drug is suggested more liberally according to the physician’s discretion. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한고혈압학회 | - |
dc.title | 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 신진호 | - |
dc.contributor.affiliatedAuthor | 김근호 | - |
dc.identifier.doi | 10.1186/s40885-014-0013-2 | - |
dc.identifier.bibliographicCitation | Clinical Hypertension, v.21, no.2, pp.1 - 13 | - |
dc.relation.isPartOf | Clinical Hypertension | - |
dc.citation.title | Clinical Hypertension | - |
dc.citation.volume | 21 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 13 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001982665 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Antihypertensive treatment | - |
dc.subject.keywordAuthor | Cardiovascular risk | - |
dc.subject.keywordAuthor | Guidelines | - |
dc.subject.keywordAuthor | Hypertension | - |
dc.subject.keywordAuthor | Lifestyle | - |
dc.subject.keywordAuthor | Organdamage | - |
dc.identifier.url | https://clinicalhypertension.biomedcentral.com/articles/10.1186/s40885-014-0013-2 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.